Andra AP fonden bought a new position in Xylem Inc. (NYSE:XYL – Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 80,884 shares of the industrial products company’s stock, valued at approximately $9,666,000.
A number of other institutional investors have also recently made changes to their positions in XYL. AQR Capital Management LLC raised its holdings in Xylem by 14.4% in the 1st quarter. AQR Capital Management LLC now owns 30,955 shares of the industrial products company’s stock worth $3,645,000 after acquiring an additional 3,900 shares during the last quarter. NewEdge Advisors LLC boosted its stake in Xylem by 3.3% during the 1st quarter. NewEdge Advisors LLC now owns 4,151 shares of the industrial products company’s stock valued at $496,000 after purchasing an additional 132 shares during the last quarter. Empowered Funds LLC boosted its stake in Xylem by 56.1% during the 1st quarter. Empowered Funds LLC now owns 8,678 shares of the industrial products company’s stock valued at $1,037,000 after purchasing an additional 3,120 shares during the last quarter. Arrowstreet Capital Limited Partnership increased its holdings in shares of Xylem by 97.6% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 11,151 shares of the industrial products company’s stock worth $1,442,000 after purchasing an additional 5,509 shares in the last quarter. Finally, EverSource Wealth Advisors LLC raised its stake in shares of Xylem by 114.0% in the second quarter. EverSource Wealth Advisors LLC now owns 1,192 shares of the industrial products company’s stock worth $154,000 after purchasing an additional 635 shares during the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.
Xylem Stock Performance
Shares of NYSE XYL opened at $116.91 on Wednesday. Xylem Inc. has a 12-month low of $105.29 and a 12-month high of $154.27. The firm has a market capitalization of $27.79 billion, a price-to-earnings ratio of 29.08, a price-to-earnings-growth ratio of 1.72 and a beta of 1.03. The company has a current ratio of 1.46, a quick ratio of 1.10 and a debt-to-equity ratio of 0.13. The firm has a 50 day moving average of $113.51 and a 200 day moving average of $123.12.
Xylem Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Thursday, June 25th. Shareholders of record on Thursday, May 28th were given a $0.43 dividend. The ex-dividend date was Thursday, May 28th. This represents a $1.72 dividend on an annualized basis and a yield of 1.5%. Xylem’s dividend payout ratio is presently 42.79%.
Insider Transactions at Xylem
In related news, Director Jerome A. Peribere acquired 1,210 shares of the firm’s stock in a transaction dated Monday, May 4th. The shares were purchased at an average price of $116.61 per share, with a total value of $141,098.10. Following the completion of the purchase, the director directly owned 27,209 shares of the company’s stock, valued at $3,172,841.49. This represents a 4.65% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of the company’s stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $117.46, for a total transaction of $501,436.74. Following the completion of the transaction, the chief accounting officer owned 3,605 shares of the company’s stock, valued at approximately $423,443.30. The trade was a 54.22% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 0.32% of the company’s stock.
Wall Street Analyst Weigh In
Several research firms have issued reports on XYL. Jefferies Financial Group upgraded shares of Xylem from a “hold” rating to a “buy” rating and upped their target price for the company from $130.00 to $140.00 in a research note on Thursday, June 25th. Stifel Nicolaus reduced their price target on shares of Xylem from $159.00 to $157.00 and set a “buy” rating for the company in a research note on Monday. JPMorgan Chase & Co. decreased their price objective on shares of Xylem from $170.00 to $160.00 and set an “overweight” rating for the company in a report on Thursday, April 16th. UBS Group increased their price objective on shares of Xylem from $132.00 to $133.00 and gave the company a “neutral” rating in a research report on Wednesday, April 29th. Finally, Weiss Ratings downgraded shares of Xylem from a “hold (c+)” rating to a “hold (c)” rating in a research report on Friday, May 8th. Eight analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $153.15.
Read Our Latest Analysis on Xylem
Xylem Profile
Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
See Also
- Five stocks we like better than Xylem
- Confidence Is Back, But Earnings Show the Consumer Is Being Picky
- AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off
- 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative?
- 3 Photonics Companies Making Quantum Tech Possible
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
